158 related articles for article (PubMed ID: 3020615)
1. Roles of leukotrienes in two rat allergic inflammatory models; IgE-mediated and IgG-antigen complex-induced pleurisies.
Tanaka K; Ueno A; Katori M
Prostaglandins; 1986 Jun; 31(6):1099-116. PubMed ID: 3020615
[TBL] [Abstract][Full Text] [Related]
2. Role of leukotrienes in rat reversed passive Arthus pleurisy and the effect of AA-861, a 5-lipoxygenase inhibitor.
Makino H; Ashida Y; Saijo T; Kuriki H; Terao S; Maki Y
Int Arch Allergy Appl Immunol; 1986; 79(1):38-44. PubMed ID: 3000949
[TBL] [Abstract][Full Text] [Related]
3. Difference in the in vitro metabolism of leukotrienes in the exudates from allergic and nonallergic rat pleurisies.
Ueno A; Tanaka K; Katori M
Prostaglandins; 1986 May; 31(5):833-50. PubMed ID: 2873627
[TBL] [Abstract][Full Text] [Related]
4. Involvement of leukotrienes in allergic pleurisy in actively sensitized rats: inhibition by the lipoxygenase inhibitor T-0757 of the increase in vascular permeability and leukotriene E4 production.
Kikuchi M; Tsuzurahara K; Suzuki T; Yato N; Naito K
Inflamm Res; 1996 Apr; 45(4):192-7. PubMed ID: 8741009
[TBL] [Abstract][Full Text] [Related]
5. Involvement of leukotriene B4 in zymosan-induced rat pleurisy: inhibition of leukocyte infiltration by the 5-lipoxygenase inhibitor T-0757.
Kikuchi M; Tsuzurahara K; Naito K
Biol Pharm Bull; 1995 Sep; 18(9):1302-4. PubMed ID: 8845830
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor.
Ashida Y; Saijo T; Kuriki H; Makino H; Terao S; Maki Y
Prostaglandins; 1983 Dec; 26(6):955-72. PubMed ID: 6084855
[TBL] [Abstract][Full Text] [Related]
7. Time course analyses of kinins and other mediators in plasma exudation of rat kaolin-induced pleurisy.
Hori Y; Jyoyama H; Yamada K; Takagi M; Hirose K; Katori M
Eur J Pharmacol; 1988 Aug; 152(3):235-45. PubMed ID: 3065090
[TBL] [Abstract][Full Text] [Related]
8. Involvement of platelet-activating factor in zymosan-induced rat pleurisy.
Imai Y; Hayashi M; Oh-ishi S
Lipids; 1991 Dec; 26(12):1408-11. PubMed ID: 1819742
[TBL] [Abstract][Full Text] [Related]
9. Pleural fluid eosinophils suppress local IgE-mediated protein exudation in rats.
Bandeira-Melo C; e Silva PM; Cordeiro RS; Martins MA
J Leukoc Biol; 1995 Oct; 58(4):395-402. PubMed ID: 7561515
[TBL] [Abstract][Full Text] [Related]
10. Role of leukotrienes in vascular changes in the rat mesentery and skin in anaphylaxis.
Leng W; Kuo CG; Qureshi R; Jakschik BA
J Immunol; 1988 Apr; 140(7):2361-8. PubMed ID: 3351303
[TBL] [Abstract][Full Text] [Related]
11. Release of peptide leukotrienes from rat Kupffer cells.
Sakagami Y; Mizoguchi Y; Seki S; Kobayashi K; Morisawa S; Yamamoto S
Biochem Biophys Res Commun; 1988 Oct; 156(1):217-21. PubMed ID: 2845972
[TBL] [Abstract][Full Text] [Related]
12. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
Majima M; Kawashima N; Hiroshi I; Katori M
Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140
[TBL] [Abstract][Full Text] [Related]
13. Leukotrienes, allergy and inflammation.
Nijkamp FP; Sitsen JM
Pharm Weekbl Sci; 1982 Dec; 4(6):165-71. PubMed ID: 6296757
[TBL] [Abstract][Full Text] [Related]
14. Involvement of histamine in vascular permeability increase of the rat pleurisy induced by phorbol myristate acetate.
Kikuchi M; Oh-ishi S
Jpn J Pharmacol; 1985 Dec; 39(4):467-73. PubMed ID: 4094190
[TBL] [Abstract][Full Text] [Related]
15. Effects of TZI-41127, a novel selective 5-lipoxygenase inhibitor, on A23187-induced pleurisy in rats.
Hagiwara M; Mikami T; Iwamura S; Miyazawa K; Kobayashi M; Miyasaka K
Eur J Pharmacol; 1991 Jun; 199(1):69-75. PubMed ID: 1909963
[TBL] [Abstract][Full Text] [Related]
16. Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs. Influence of 5-lipoxygenase inhibitors.
Schulz R; Seeger W
Biochem Pharmacol; 1986 Jan; 35(2):183-93. PubMed ID: 3002385
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.
Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; Oglesby TD; Wasley JW
Biochim Biophys Acta; 1988 Apr; 959(3):332-42. PubMed ID: 2833314
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of leukotriene C4, D4 and E4 in allergic inflammation in rats.
Ohuchi K; Takahashi C; Watanabe M; Hirasawa N; Suzuki Y; Kudo M; Konishi T; Tsurufuji S
J Clin Lab Immunol; 1988 Dec; 27(4):171-8. PubMed ID: 2855079
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of formation and further metabolism of leukotrienes in the chopped human lung.
Kumlin M; Dahlén SE
Biochim Biophys Acta; 1990 May; 1044(2):201-10. PubMed ID: 2160839
[TBL] [Abstract][Full Text] [Related]
20. Leukotrienes as mediators in frog virus 3-induced hepatitis in rats.
Hagmann W; Steffan AM; Kirn A; Keppler D
Hepatology; 1987; 7(4):732-6. PubMed ID: 3111968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
